middle.news
How EMVision’s Brain Scanners Are Poised to Transform Stroke Care Despite FY25 Losses
2:31am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
How EMVision’s Brain Scanners Are Poised to Transform Stroke Care Despite FY25 Losses
2:31am on Saturday 30th of August, 2025 AEST
Key Points
FY25 loss surged to $9.8 million, revenue down 51%
Promising clinical trial results for emu™ point-of-care brain scanner
Pivotal trial underway with global clinical consortium
Secured $8 million in non-dilutive government grants
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Emvision Medical Devices (ASX:EMV)
OPEN ARTICLE